BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7184398)

  • 1. [Recovery from cyclophosphamide-induced myelosuppression accelerated by bestatin].
    Uchida K; Kohi F; Yorimitsu S; Takahashi I; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):220-4. PubMed ID: 7184398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined interleukin 1 beta/interleukin 2 treatment in mice: synergistic myelostimulatory activity and protection against cyclophosphamide-induced myelosuppression.
    Proietti E; Tritarelli E; Gabriele L; Testa U; Greco G; Pelosi E; Gabbianelli M; Belardelli F; Peschle C
    Cancer Res; 1993 Feb; 53(3):569-76. PubMed ID: 8425189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual marrow damage following therapy with cyclophosphamide.
    Fried W; Barone J
    Exp Hematol; 1980 May; 8(5):610-4. PubMed ID: 7007067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
    Patchen ML; Fischer R; MacVittie TJ
    Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemostimulant effect of pantohematogen in myelosuppression induced by cytostatics].
    Dygaĭ AM; Gur'iantseva LA; Zhdanov VV; Pozhen'ko NS; Simanina EV; Suslov NI; Gol'dberg VE
    Eksp Klin Farmakol; 2000; 63(6):34-6. PubMed ID: 11202509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
    DiBenedetto J; Higby DJ; Chester SJ; Albala MM
    J Med; 1980; 11(5-6):385-92. PubMed ID: 6962825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acceleration of myeloid recovery from cyclophosphamide-induced leukopenia by pretreatment with Bacillus Calmette-Guérin.
    Ladisch S; Poplack DG; Bull JM
    Cancer Res; 1978 Apr; 38(4):1049-51. PubMed ID: 639036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic and hematologic properties of bestatin in normal and cyclophosphamide myelosuppressed mice.
    Talmadge JE; Black PL; Pelus LM; Abe F
    Biomed Pharmacother; 1990; 44(2):85-91. PubMed ID: 2224059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a novel compound BIV-30 on bone-marrow hematopoiesis in myelosuppression induced by lead acetate].
    Baktybaeva LK
    Eksp Klin Farmakol; 2011; 74(2):26-8. PubMed ID: 21476282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation.
    Chen T; Burke KA; Zhan Y; Wang X; Shibata D; Zhao Y
    Exp Hematol; 2007 Feb; 35(2):203-13. PubMed ID: 17258069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical effect of hypertransfusion and OK-432 on granulocyte recovery].
    Nomura T; Kato Y; Atsumi S; Kawaguchi H; Mori F; Shimizu S; Kawamura Y; Kamiya H; Sakurai M; Yatani R
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1850-7. PubMed ID: 6576731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.
    Talmadge JE; Pelus LM; Black PL; Abe F
    Biomed Pharmacother; 1991; 45(2-3):61-9. PubMed ID: 1912371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice.
    Abe F; Matsuda A; Schneider M; Talmadge JE
    Cancer Immunol Immunother; 1990; 32(2):75-80. PubMed ID: 2289207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice.
    Xu SF; Yu LM; Fan ZH; Wu Q; Yuan Y; Wei Y; Fang N
    Eur J Pharmacol; 2012 Nov; 695(1-3):7-12. PubMed ID: 22940261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide regimens in rhesus monkey with and without marrow infusion.
    Storb R; Buckner CD; Dillingham LA; Thomas ED
    Cancer Res; 1970 Aug; 30(8):2195-203. PubMed ID: 4990004
    [No Abstract]   [Full Text] [Related]  

  • 18. Accelerated hematopoietic recovery with the hemoregulatory peptide dimer SK&F 107647 in bone marrow transplantation.
    Veiby OP; Olsen WM
    Bone Marrow Transplant; 1995 Feb; 15(2):305-11. PubMed ID: 7773223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of astragalus membranaceus and ligustrum lucidum does not prevent cyclophosphamide-induced myelosuppression.
    Khoo KS; Ang PT
    Singapore Med J; 1995 Aug; 36(4):387-90. PubMed ID: 8919152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of colchicine-induced hemopoietic recovery in irradiated mice.
    Brecher G; Smith WW; Wilson S; Fred S
    Radiat Res; 1967 Mar; 30(3):600-10. PubMed ID: 6022219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.